SCHEMBL7018265

SCHEMBL7018265

C=CCOC(=O)Nc1cc(OC)cc(C(CC)Nc2cc(N3CCOCC3)cc(CSc3ncc(CC)s3)n2)c1

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
NPY1R P25929 12/20 0.41
KCNH2 Q12809 5/20 0.41
FGFR2 P21802 1/20 0.33
FGFR3 P22607 1/20 0.33
ZAP70 P43403 1/20 0.32
LCK P06239 2/20 0.31
CSF1R P07333 1/20 0.31
DHFR P00374 1/20 0.30
TP53 P04637 1/20 0.30
POLB P06746 1/20 0.30
MAPT P10636 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7019087 0.90 NPY1R (0.40) NPY1RKCNH2
SCHEMBL7013728 0.87 NPY1R (0.46) NPY1RKCNH2ZAP70
SCHEMBL7015321 0.81 NPY1R (0.42) NPY1RKCNH2TP53POLBMAPT
SCHEMBL7010941 0.81 NPY1R (0.48) NPY1RKCNH2FGFR2FGFR3LCK
SCHEMBL7009349 0.81 NPY1R (0.48) NPY1RKCNH2
SCHEMBL7019260 0.80 NPY1R (0.56) NPY1RKCNH2
SCHEMBL7015274 0.79 NPY1R (0.46) NPY1R
SCHEMBL7020364 0.79 NPY1R (0.45) NPY1RKCNH2ZAP70
SCHEMBL7019857 0.79 NPY1R (0.48) NPY1RKCNH2
SCHEMBL7015017 0.79 NPY1R (0.45) NPY1RKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0889034-B1 AMINOPYRIDINE DERIVATIVES BANYU PHARMA CO LTD (JP) 2003-09-17 EP disclosed
US-6011039-A USEFUL AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS; TREATING HYPERPHAGIA, OBESITY OR DIABETES BANYU PHARMACEUTICAL CO., LTD. (JP) 2000-01-04 US disclosed
EP-0889034-A1 AMINOPYRIDINE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1999-01-07 EP disclosed